Healthcare
China’s first biosimilar Ozempic drug applies for approval
A CHINESE drugmaker has developed a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic and applied for its approval.
Hangzhou Jiuyuan Gene Engineering said on Wednesday (Apr 3) in...
Drugmaker seeks approval for China’s first biosimilar Ozempic
A DRUGMAKER in China has developed a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic and applied for approval to sell it there, in a potential challenge to...
Europe: Stocks dragged down by healthcare; German inflation data in focus
EUROPEAN stocks made a downbeat start to the second quarter, pressured by healthcare shares, while investors parsed inflation data from the continent’s largest economy Germany for clues on the...
Healthcare Technology Expert Breaks Down the Blueprint of Successful Patient-Centric Healthcare Systems
"There's a growing emphasis in today's healthcare landscape on creating systems that deliver tangible improvements in patient care and accessibility," remarks Sripriya Bayyapu, a renowned healthcare technology expert. As...
Kobayashi Pharma ordered to recall red yeast rice pills after 2 deaths
JAPANESE authorities on Wednesday (Mar 27) ordered drugmaker Kobayashi Pharmaceutical to recall three dietary supplement products containing red yeast rice, or beni koji, after they were linked to two...
American Healthcare Academy Celebrates 14 Years of commitment to healthcare education
The American Healthcare Academy (AHCA) is a key provider of healthcare certifications, marking its 14th anniversary. Throughout its journey, AHCA has prioritized inclusive and accessible healthcare education. The company's...
Private healthcare providers brace for higher costs amid global shortage of nurses
OPERATING expenditures for private healthcare players in Singapore are expected to rise as they reassess their compensation for nurses, although the costs to retain staff could still be lower...